External use of mirabilite to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis in children: A multicenter randomized controlled trial

doi:10.4240/wjgs.v15.i4.712

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2648)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-6) series.

Item

Count

PDF

WORD

HTML

1125

Figures (1-1)

125

Tables (1-6)

124

Sum=1492

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

132

Download

394

Sum=526

Publishing Process of This Article

Item

Count

Browse

154

Download

476

Sum=630

Apr 27, 2023 (publication date) through Jul 8, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Gastrointest Surg. Apr 27, 2023; 15(4): 712-722
Published online Apr 27, 2023. doi: 10.4240/wjgs.v15.i4.712

Table 2 Incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in each group

	External use of mirabilite group (n = 117)	Blank group (n = 117)	P value
Overall			< 0.001¹
PEP	9 (7.7%)	31 (26.5%)
No PEP	108 (92.3%)	86 (73.5%)
< 6 years old			0.001¹
PEP	1 (2.1%)	14 (27.5%)
No PEP	46 (97.9%)	37 (72.5%)
≥ 6 years old			0.031¹
PEP	8 (11.4%)	17 (25.8%)
No PEP	62 (84.7%)	49 (74.2%)

¹Statistically significant.

PEP: Post-endoscopic retrograde cholangiopancreatography pancreatitis.

Citation: Zeng JQ, Zhang TA, Yang KH, Wang WY, Zhang JY, Hu YB, Xiao J, Gu ZJ, Gong B, Deng ZH. External use of mirabilite to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis in children: A multicenter randomized controlled trial. World J Gastrointest Surg 2023; 15(4): 712-722
URL: https://www.wjgnet.com/1948-9366/full/v15/i4/712.htm
DOI: https://dx.doi.org/10.4240/wjgs.v15.i4.712